Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Free Cash Flow (2016 - 2025)

Skinvisible (SKVI) has disclosed Free Cash Flow for 16 consecutive years, with $1975.0 as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 111.68% to $1975.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$38409.0 through Dec 2025, up 45.0% year-over-year, with the annual reading at -$42496.0 for FY2025, 46.24% up from the prior year.
  • Free Cash Flow hit $1975.0 in Q4 2025 for Skinvisible, up from $525.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $166292.0 in Q2 2021 to a low of -$52240.0 in Q1 2023.
  • Historically, Free Cash Flow has averaged $10182.6 across 5 years, with a median of -$12416.5 in 2024.
  • Biggest five-year swings in Free Cash Flow: soared 409.71% in 2021 and later tumbled 340.07% in 2024.
  • Year by year, Free Cash Flow stood at $153814.0 in 2021, then crashed by 129.93% to -$46035.0 in 2022, then soared by 91.65% to -$3843.0 in 2023, then crashed by 340.07% to -$16912.0 in 2024, then surged by 111.68% to $1975.0 in 2025.
  • Business Quant data shows Free Cash Flow for SKVI at $1975.0 in Q4 2025, $525.0 in Q3 2025, and -$9189.0 in Q2 2025.